Cargando…
Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia
OBJECTIVE: Here, the aim is to improve the bioavailability of Naringenin (NRG) in brain and to establish the highest remedial benefit from a novel anti-ischemic medicine i.e. NRG. METHODS: A novel Naringenin-loaded-nanoemulsion (NE)-(in situ)-gel (i.e. thermoresponsive), was formulated with the help...
Autores principales: | Ahmad, Niyaz, Ahmad, Rizwan, Ahmad, Farhan Jalees, Ahmad, Wasim, Alam, Md Aftab, Amir, Mohd, Ali, Abuzer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933235/ https://www.ncbi.nlm.nih.gov/pubmed/31889876 http://dx.doi.org/10.1016/j.sjbs.2019.11.008 |
Ejemplares similares
-
Quantification of rutin in rat's brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles
por: Ahmad, Niyaz, et al.
Publicado: (2016) -
Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles
por: Ahmad, Niyaz, et al.
Publicado: (2018) -
A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
por: Ahmad, Niyaz, et al.
Publicado: (2019) -
Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats
por: Bin Jardan, Yousef A., et al.
Publicado: (2021) -
Tamarindus indica Fruit: Pharmacognostical Standardization, Detection of Contaminant, and In Vitro Antioxidant Activity
por: Amir, Mohd, et al.
Publicado: (2019)